Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Cooper

Showing results (271-280 of 291) with videos related to

Pageof 30
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 16, 2020
Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysisSofia Spampinato, Lars U Fokdal, Richard Pötter, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2020
Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I StudyNina B K Jensen, Richard Pötter, Sofia Spampinato, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 2021
Response to Yuce Sari et alSofia Spampinato, Lars U Fokdal, Richard Pötter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2021
Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysisSofia Spampinato, Lars U Fokdal, Richard Pötter, et al.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2021
Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I StudyKathrin Kirchheiner, Stéphanie Smet, Ina M Jürgenliemk-Schulz, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2023
Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I StudyAnders Schwartz Vittrup, Kathrin Kirchheiner, Richard Pötter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 31, 2023
Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivorsSofia Spampinato, Kari Tanderup, Jacob C Lindegaard, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I StudyJacob Christian Lindegaard, Primoz Petric, Maximilian Paul Schmid, et al.
The Lancet. Oncology|April 1, 2021
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort studyRichard Pötter, Kari Tanderup, Maximilian Paul Schmid, et al.
Msystems|October 10, 2019
Current State of and Future Opportunities for Prediction in Microbiome Research: Report from the Mid-Atlantic Microbiome Meet-up in Baltimore on 9 January 2019Eric Sakowski, Gherman Uritskiy, Rachel Cooper, et al.
Pageof 30

Showing results (271-280 of 291) with videos related to

Sort By:
Pageof 30
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 16, 2020
Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysisSofia Spampinato, Lars U Fokdal, Richard Pötter, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2020
Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I StudyNina B K Jensen, Richard Pötter, Sofia Spampinato, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 2021
Response to Yuce Sari et alSofia Spampinato, Lars U Fokdal, Richard Pötter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2021
Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysisSofia Spampinato, Lars U Fokdal, Richard Pötter, et al.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2021
Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I StudyKathrin Kirchheiner, Stéphanie Smet, Ina M Jürgenliemk-Schulz, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2023
Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I StudyAnders Schwartz Vittrup, Kathrin Kirchheiner, Richard Pötter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 31, 2023
Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivorsSofia Spampinato, Kari Tanderup, Jacob C Lindegaard, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I StudyJacob Christian Lindegaard, Primoz Petric, Maximilian Paul Schmid, et al.
The Lancet. Oncology|April 1, 2021
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort studyRichard Pötter, Kari Tanderup, Maximilian Paul Schmid, et al.
Msystems|October 10, 2019
Current State of and Future Opportunities for Prediction in Microbiome Research: Report from the Mid-Atlantic Microbiome Meet-up in Baltimore on 9 January 2019Eric Sakowski, Gherman Uritskiy, Rachel Cooper, et al.
Pageof 30